Proton beam therapy in patients with breast cancer: evaluating early and late effects - Trial ISRCTN14220944
Access comprehensive clinical trial information for ISRCTN14220944 through Pure Global AI's free database. This phase not specified trial is sponsored by Institute of Cancer Research and is currently status unknown. The study focuses on Malignant neoplasm of breast. Target enrollment is 192 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institute of Cancer Research
NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC); Grant Codes: NIHR131120
Timeline & Enrollment
N/A
Nov 27, 2019
Feb 01, 2030
Summary
PARABLE aims to show that proton beam therapy (PBT) reduces the predicted risk of late serious heart toxicity with no increase in other shorter-term side effects compared with tailored photon radiotherapy (intensity‐modulated arc therapy). PARABLE's specific objectives are to: 1. Change international practice for breast PBT early with a primary outcome analysis at 2 years' follow-up 2. Improve the understanding of PBT biological models through a mechanistic study with potential benefit for all cancer patients needing PBT.
ICD-10 Classifications
Data Source
ISRCTN Registry
ISRCTN14220944
Non-Device Trial